Dr James Michael Foley, DED in Alfred, ME - Psychologist

Dr James Michael Foley, DED is a Psychologist - Clinical based in Alfred, Maine. Dr James Michael Foley is licensed to practice in Maine (license number 0411) and his current practice location is 12 Waterboro Rd, Alfred, Maine. He can be reached at his office (for appointments etc.) via phone at (207) 929-3663.

NPI number for Dr James Michael Foley is 1316017361 and his current mailing address is 12 Waterboro Rd, Alfred, Maine. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1316017361.

Contact Information

	Dr James Michael Foley, DED
	12 Waterboro Rd, Alfred, ME 04002-3243
	(207) 929-3663
	Not Available

Healthcare Provider's Profile

Full Name	Dr James Michael Foley
Gender	Male
Speciality	Psychologist - Clinical
Location	12 Waterboro Rd, Alfred, Maine
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1316017361
Provider Enumeration Date: 11/08/2006
Last Update Date: 05/17/2009

Medical Identifiers

Medical identifiers for Dr James Michael Foley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316017361	NPI	-	NPPES
211180000	Medicaid	ME

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TC0700X	Psychologist - Clinical	0411 (Maine)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr James Michael Foley is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr James Michael Foley, DED 12 Waterboro Rd, Alfred, ME 04002-3243 Ph: (207) 929-3663	Dr James Michael Foley, DED 12 Waterboro Rd, Alfred, ME 04002-3243 Ph: (207) 929-3663

News Archive

Tibotec Pharmaceuticals submits NDA for investigational HIV treatment

Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.

Nociceptin receptor is associated with PTSD resilience after trauma

Fewer receptors for the anti-stress brain chemical nociceptin is associated with less severe posttraumatic stress disorder symptoms in college women who have experienced sexual violence, according to a study in Biological Psychiatry, published by Elsevier.

How consumer behavior is affected by ideas of mortality - called mortality salience

In our post 9/11 world, Americans demand more-more food, more drink, more time with friends and family, and more time for religion.

Oxford University researchers find that a blood test could predict rheumatoid arthritis risk

Scientists have found a marker that can indicate your likelihood of suffering from rheumatoid arthritis (RA) even sixteen years before the condition takes effect. A team from the Kennedy Institute of Rheumatology at Oxford University found that a blood test that looks for antibodies that recognize the protein tenascin-C could reliably show those who will contract the condition.

COVID-19 Simulator shows how lifting or extending social-distancing measures will impact states

A new online tool, COVID-19 Simulator, developed by researchers at Massachusetts General Hospital and Georgia Tech can help policy makers see how lifting or extending different social-distancing measures at various times can impact each state in terms of COVID-19 cases, hospitalizations, and deaths.

Dr James Michael Foley, DED - Psychologist in Alfred, ME